SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

Jan 4 2023
BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Jan. 4, 2023-- SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023 , at 8:15 a.m.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Associate Sales Executive - U.S. South and West United States Clinical Sales
IVDR Expert (Regulatory Affairs) Switzerland. United Kingdom. United States Regulatory & Quality
Subject Matter Expert - APAC Malaysia. Singapore Clinical Sales
Senior Director, Clinical & BioPharma Operations Switzerland Medical
Sr Manager, Genomic Implementation Solutions United States Clinical Sales